close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Oscar Lahoud

location-icon

Brooklyn, NY

LOCATION OF PRACTICE
Nyu Langone Hospitals
MEDICAL Specialty:

Multiple Myeloma, Osteosarcoma, Retroperitoneum Cancer



2236 NOSTRAND AVE, BROOKLYN, NY, 112103037
2236 NOSTRAND AVE, BROOKLYN, NY, 112103037
516-559-1523
NPI Number
1972731776
ABOUT

Oscar Lahoud, MD, is a hematologist in New York, NY. He has 16 years of experience and is board certified in Hematology, frequently treating conditions such as Osteosarcoma and Multiple Myeloma. Lahoud graduated from the University of Michigan / Ann Arbor and is affiliated with NYU Langone Hospitals.

Dr. Oscar Lahoud profile image

Published Articles

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.- 2026 Apr
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.- 2026 Apr 1
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience.- 2025 Aug
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.- 2025 Sep 4
A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation.- 2025 Apr
Evaluating serum free light chain ratio as a biomarker in multiple myeloma.- 2025 Feb 1
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma.- 2024 Sep 19
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity.- 2024 Nov 12
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma.- 2024 Jun 5
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.- 2024 May 31

Clinical Trials

Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS

Other Specialists treating Multiple Myeloma, Osteosarcoma, Retroperitoneum Cancer in Brooklyn, NY

See All Doctors

Dr. Gardith Joseph

Specialty: Neutropenia, Anemia, Osteosarcoma

My Resources
location-icon

NYU Langone Hospitals

My Resources

Dr. Phyllis Hyde

Specialty: Breast Cancer, Hemophilia, Osteosarcoma

My Resources
location-icon

New York Presbyterian Hospital

My Resources

Dr. Ramsey Asmar

Specialty: Retroperitoneum Cancer, Anemia, Diffuse Large B-Cell Lymphoma

My Resources
location-icon

Morristown Medical Center

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider